Key points GLP-1 is a hormone that increases insulin release and prevents the release of too much glucagon, helping manage blood glucose levels in individuals with type 2 diabetes GLP-1 receptor agonists, such as liraglutide and semaglutide, effectively reduce blood glucose levels Semaglutide is more effective than liraglutide at reducing blood sugar levels Tirzepatide is a newer GLP-1 receptor agonist that also mimics the actions of another hormone called GIP, which can also reduce blood sugar levels A randomised controlled trial showed that tirzepatide led to more significant blood sugar reductions than semaglutide across three doses Tirzepatide may be more effective than semaglutide at higher doses, but this needs further investigation Liraglutide and semaglutide are available in the UK and the US, while tirzepatide is only available in the US but is likely to be approved in the UK soon

Tambin permitira aumentar la masa muscular y de reducir la fatiga fsica y mental , como lo demuestran estudios realizados en adultos
Malignant melanotic nerve sheath tumor with PRKAR1A, KMT2C, and GNAQ mutations
Despite its name, research suggests DSIP has broader functions beyond sleep induction, potentially affecting neuroendocrine regulation and immune function
Remission rate after 10 years is in the order of 30% to 40%, and hypothyroidism has developed in 10% to 15% 15 years after ATD [59]